Page last updated: 2024-11-04

vorinostat and Visceral Pain

vorinostat has been researched along with Visceral Pain in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Visceral Pain: Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, DY1
Bai, G1
Ji, Y1
Traub, RJ1
Moloney, RD1
Stilling, RM1
Dinan, TG1
Cryan, JF1

Other Studies

2 other studies available for vorinostat and Visceral Pain

ArticleYear
Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity.
    Gut, 2015, Volume: 64, Issue:12

    Topics: Acetylation; Amino Acids; Animals; Disease Models, Animal; Epigenesis, Genetic; Estradiol; Estrogens

2015
Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition.
    Neurogastroenterology and motility, 2015, Volume: 27, Issue:12

    Topics: Animals; Anxiety; Blotting, Western; Disease Models, Animal; Female; Histone Deacetylase Inhibitors;

2015